Trial Profile
A Randomized, Double-blind, Multi-center, Placebo-controlled, Dose-ranging, Efficacy and Safety Trial of a New Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts (Verruca Vulgaris)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2019
Price :
$35
*
At a glance
- Drugs Santalum album (Primary)
- Indications Warts
- Focus Therapeutic Use
- Sponsors ViroXis
- 03 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 13 Dec 2013 Planned end date changed from 1 Jul 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov record.